## 3 Results  
In total, 28 patients participated in the study. Considering Table 1, there were no significant baseline differences between both groups in any of sociodemographic data and clinical measurements. Most of the painful knees were the patient's right knee (87%) because there were 26 subjects with dominance on the right side and four subjects with dominance on the left side.  
Regarding Table 2, intrasubject (time) statistically significant differences with a large effect size were shown for knee flexion ROM [F(3,78) = 47.998; \(p\) = 0.001; Eta2 = 0.649], NSR [F(3,78) = 11.562; \(p\) = 0.001; Eta2 = 0.308], Kujala [F(3,78) = 6.835; \(p\) = 0.001; Eta2 = 0.208]) and VISA-P [F(3,78) = 4.054; \(p\) = 0.01; Eta2 = 0.135] variables. In addition, the [PERSON]'s correction post-hoc analyses showed statistically significant differences from baseline to 1 week for the Kujala score, knee flexion ROM, and NRS variables. VISA-P score did not show statistically significant differences for the time-group interaction. Finally, there were no intergroup statistically significant differences.  
\begin{table}
\begin{tabular}{c c c c} \hline \hline
**Data** & **Asymptomatic Knee Group** & **Symptomatic Knee Group** & **\(p\)-Value** \\  & **(n = 15)** & **(n = 15)** & **(n = 15)** \\ \hline Age (years) & 37.0 \(\pm\) 9.6 & 39.3 \(\pm\) 9.5 & 0.52 \\ Weight (kg) & 71.7 \(\pm\) 8.9 & 65.6 \(\pm\) 9.5 & 0.09 \\ Height (m) & 1.68 \(\pm\) 0.09 & 1.65 \(\pm\) 0.06 & 0.30 \\ BMI (kg/m\({}^{2}\)) & 25.5 \(\pm\) 3.5 & 24.0 \(\pm\) 2.7 & 0.26 \\ Injury time (months) & 7.0 \(\pm\) 2.6 & 7.2 \(\pm\) 2.7 & 0.82 \\ Gender (F/M) & 11/4 & 10/5 & N/A \\ Dominance side (R/L) & 14/1 & 12/3 & N/A \\ Pathological side (R/L) & 13/2 & 12/3 & N/A \\ ROM (o) & 129.0 \(\pm\)11.70 & 133.5 \(\pm\) 6.4 & 0.228 \\ NRS & 56.4 \(\pm\) 14.56 & 56.9 \(\pm\) 18.88 & 0.939 \\ Kajala & 78.8 \(\pm\) 10.60 & 73.2 \(\pm\) 6.70 & 0.116 \\ VISA-P score & 59.0 \(\pm\) 12.90 & 50.2 \(\pm\) 18.90 & 0.102 \\ \hline \hline \end{tabular}
\end{table}
Table 1: Sociodemographic data and baseline values of clinical variables for each group.  
\begin{table}
\begin{tabular}{c c c c c} \hline \hline  & & & **Intrasubject Effects** \\ \hline
**Measure** & **Asymptomatic Knee Group (n = 15)** & **Symptomatic Knee Group (n = 13)** & **Time Value** & **Intervention X Time** \\  & **Group (n = 15)** & **Group (n = 13)** & **F (Db); P (Eta2)** & **F (Df); P (Eta2)** \\ \hline
**ROM (\({}^{\star}\))** & & & F (3,78) = 47.998; & F (3,78) = 0.387; \\ Baseline & 129.0 \(\pm\) 11.70 & 133.5 \(\pm\) 6.4 & & \\ Post-intervention & 137.0 \(\pm\) 6.50 \({}^{\star}\) & 140.6 \(\pm\) 5.70 \({}^{\star}\) & & \\
24 h & 142.2 \(\pm\) 7.19 \({}^{\star}\) & 147.0 \(\pm\) 5.10 \({}^{\star}\) & & \\
1 week & 146.2 \(\pm\) 6.50 \({}^{\star}\) & 148.5 \(\pm\) 4.50 \({}^{\star}\) & & \\
**NRS** & & & F (3,78) = 11.562; & F (3,78) = 0.725; \\ Baseline & 56.4 \(\pm\) 14.56 & 56.9 \(\pm\) 18.88 & & \\ Post-intervention & 48.3 \(\pm\) 17.19 & 45.8 \(\pm\) 23.08 & & \\
24 h & 42.8 \(\pm\) 17.64 & 40.6 \(\pm\) 16.77 & & \\
1 week & 42.3 \(\pm\) 23.10 & 33.1 \(\pm\) 21.05 \({}^{\star}\) & & \\
**Kujala score** & & & F (3,78) = 6.835; & F (3,78) = 3.043; \\ Baseline & 78.8 \(\pm\) 10.60 & 73.2 \(\pm\) 6.70 & & \\ Post-intervention & 80.8 \(\pm\) 10.90 & 77.2 \(\pm\) 8.96 & & \\
24 h & 82.7 \(\pm\) 9.90 & 80.0 \(\pm\) 10.70 & & \\
1 week & 82.9 \(\pm\) 12.00 & 84.5 \(\pm\) 9.10 \({}^{\star}\) & & \\
**VISA-P score** & & & F (3,78) = 4.054; & F (3,78) = 2.044; \\ Baseline & 59.0 \(\pm\) 12.90 & 50.2 \(\pm\) 18.90 & & \\ Post-intervention & 66.7 \(\pm\) 13.30 & 55.1 \(\pm\) 15.30 & & \\
24 h & 66.1 \(\pm\) 11.40 & 52.9 \(\pm\) 14.40 & & \\
1 week & 63.4 \(\pm\) 16.20 & 60.9 \(\pm\) 17.50 & & \\ \hline \hline \end{tabular}
\end{table}
Table 2: Numeric rating score (NRS), range of motion (ROM), Kujala, and Victorian Institute of Sport Assessment-Patella (VISA-P) intrasubject effects.